- Home
- FOSL vs ADAG Comparison
FOSL vs ADAG Comparison
Compare FOSL & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOSL
- ADAG
- Stock Information
- Founded
- FOSL 1984
- ADAG 2011
- Country
- FOSL United States
- ADAG China
- Employees
- FOSL N/A
- ADAG N/A
- Industry
- FOSL Consumer Specialties
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- FOSL Consumer Discretionary
- ADAG Health Care
- Exchange
- FOSL Nasdaq
- ADAG Nasdaq
- Market Cap
- FOSL 102.2M
- ADAG 84.4M
- IPO Year
- FOSL 1993
- ADAG 2021
- Fundamental
- Price
- FOSL $1.93
- ADAG $1.88
- Analyst Decision
- FOSL Strong Buy
- ADAG Strong Buy
- Analyst Count
- FOSL 1
- ADAG 3
- Target Price
- FOSL $5.00
- ADAG $7.67
- AVG Volume (30 Days)
- FOSL 595.0K
- ADAG 82.0K
- Earning Date
- FOSL 11-13-2025
- ADAG 08-12-2025
- Dividend Yield
- FOSL N/A
- ADAG N/A
- EPS Growth
- FOSL N/A
- ADAG N/A
- EPS
- FOSL N/A
- ADAG N/A
- Revenue
- FOSL $1,083,797,000.00
- ADAG $103,204.00
- Revenue This Year
- FOSL N/A
- ADAG $7,411.34
- Revenue Next Year
- FOSL N/A
- ADAG $28.29
- P/E Ratio
- FOSL N/A
- ADAG N/A
- Revenue Growth
- FOSL N/A
- ADAG N/A
- 52 Week Low
- FOSL $0.86
- ADAG $1.30
- 52 Week High
- FOSL $4.40
- ADAG $3.16
- Technical
- Relative Strength Index (RSI)
- FOSL 41.19
- ADAG 53.39
- Support Level
- FOSL $1.79
- ADAG $1.44
- Resistance Level
- FOSL $2.09
- ADAG $1.96
- Average True Range (ATR)
- FOSL 0.16
- ADAG 0.19
- MACD
- FOSL 0.01
- ADAG 0.02
- Stochastic Oscillator
- FOSL 33.87
- ADAG 71.12
About FOSL Fossil Group Inc.
Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.